Tuesday , October 24 2017
Home / Letter From The Editor / Editor’s Note, GLP-1 Analog Special Edition, July 2015

Editor’s Note, GLP-1 Analog Special Edition, July 2015

Often when I see a patient who has started on basal insulin, they seem to do okay. But as the prescriber starts to increase the basal dose to gain A1c control, the patient frequently gain weight and that can increase non-adherence to medications. These patients have been fighting their weight for years and when they find out that insulin could be causing weight gain they are reluctant to use it. Trying to use a bolus dose of insulin may be the answer, but then we risk hypoglycemia. So for many patients a potent enough dose increases that risk.

This month we put together the latest data on the use of GLP-1 analogs to manage diabetes and weight gain, and as a bonus feature, we have the latest research on a new GLP-1 analog in a pill form.